TORONTO, June 10, 2020 (GLOBE NEWSWIRE) -- Eli Lilly and Company presented new data for OLUMIANT® (baricitinib) at the virtual European Congress of Rheumatology (EULAR 2020). Highlights from OLUMIANT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback